Symbol="BEAM"
AssetType="Common Stock"
Name="Beam TherapeuticsÂ Inc"
Description="Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1745999"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2444295000"
EBITDA="-345700000"
PERatio="None"
PEGRatio="None"
BookValue="10.55"
DividendPerShare="0"
DividendYield="0"
EPS="-4.45"
RevenuePerShareTTM="1.082"
ProfitMargin="0"
OperatingMarginTTM="-4.709"
ReturnOnAssetsTTM="-0.162"
ReturnOnEquityTTM="-0.361"
RevenueTTM="76696000"
GrossProfitTTM="-250674000"
DilutedEPSTTM="-4.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.871"
AnalystTargetPrice="66.23"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="32.42"
PriceToBookRatio="4.426"
EVToRevenue="24.39"
EVToEBITDA="-7.47"
Beta="1.575"
num_52WeekHigh="73.27"
num_52WeekLow="28.62"
num_50DayMovingAverage="32.86"
num_200DayMovingAverage="38.36"
SharesOutstanding="76218000"
DividendDate="None"
ExDividendDate="None"
symbol="BEAM"
open="31.45"
high="32.11"
low="31.00"
price="32.07"
volume="879469.00"
latest_trading_day="2023-07-21"
previous_close="30.98"
change="1.09"
change_percent="3.5184%"
aroon_positive_momentum_days="32"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="909393"
Change_recent_avg="-0.08"
Delta_recent_avg="1.52"
Variance_recent_avg="0.76"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="1103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="628"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
